Guidelines for the use of conventional and newer disease-modifying antirheumatic drugs
in elderly patients with rheumatoid arthritis.
HUMIRA is indicated for the treatment of adults with severe, active ankylosing spondylitis who have had an inadequate response to at least one nonsteroidal anti-inflammatory drug or disease-modifying antirheumatic drug
Calabrese highlighted what he termed a "thoughtful and reassuring" seven-center prospective Italian series involving 31 chronic HCV-infected patients with rheumatoid arthritis (RA) refractory to nonbiologic disease-modifying antirheumatic drugs
In terms of PsA treatment approaches, an evidence review that he and his associates in GRAPPA published in 2009 found that biologies (anti-tumor necrosis factor inhibitors) as a group were effective in all five domains of the disease: peripheral arthritis, skin and nail disease, axial disease, dactylitis, and enthesitis, while the oral disease-modifying antirheumatic drugs
(DMARDs) were effective for peripheral arthritis and skin and nail disease.
As a result, clinicians are initiating and emphasizing treatment with traditional disease-modifying antirheumatic drugs
(DMARDs) and biologics earlier in the treatment paradigm.
The drug will now be an option when the disease has responded inadequately to disease-modifying antirheumatic drugs
(DMARDs) and is already used in 1,200 patients at later stages of the disease.
Washington, June 22 (ANI): Researchers at Brigham and Women's Hospital have found that two disease-modifying antirheumatic drugs
(DMARDs) are associated with a reduced risk for the development of diabetes in psoriasis and rheumatoid arthritis patients.
The drugs are grouped by type, such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, biologic response modifiers, disease-modifying antirheumatic drugs
(DMARDs), fibromyalgia medications, osteoporosis medications and gout medications.
Drug Category: Disease-Modifying Antirheumatic Drugs
(DMARDs) for Rheumatoid Arthritis
The underlying dysregulation of cytokine signaling in JIA is typically addressed with nonsteroidal anti-inflammatory drugs and/or nonbiologic disease-modifying antirheumatic drugs
(DMARDs), such as methotrexate.
Patients were excluded if they were poor surgical candidates or were taking disease-modifying antirheumatic drugs
, biologic agents, or other bone-active agents.
XELJANZ may be used as a single agent or in combination with MTX or other non-biologic disease-modifying antirheumatic drugs
Washington, Nov 24 (ANI): A new study has found that positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs
The study did not collect information on the use of disease-modifying antirheumatic drugs
Other conventional disease-modifying antirheumatic drugs
are also highly genericized and represented only a small percentage (less than 6 percent) of market sales in 2011.